700,000 seniors have reportedly started GLP-1s since Medicare obesity-drug coverage began in July
CNBC reports that Eli Lilly CEO Dave Ricks said 70% of those new patients are on Lilly medicines. He called the coverage rollout “very encouraging.”
TLDR
CNBC reports that Eli Lilly CEO Dave Ricks said on September 21, 2026, that 700,000 seniors had started GLP-1 treatments since Medicare coverage of obesity drugs launched in July. He said 70% of those new patients were on Lilly medicines, describing the expansion of the broader GLP-1 market as “what we had hoped.”
Combined views
90.2K
2 Sources, first seen ago